The Potential of Glioblastoma Patient Symptoms to Diagnose and Predict Survival

Glioblastoma is a devastating malignancy with a dismal survival rate and median survival time of 14 months. Currently, the biomarkers for glioblastoma are mostly molecular and include EGFRvIII, ATRX, PTEN, IDH1, MGMT, and others. These prognostic tumor biomarkers are obtained through a surgical biop...

Descripción completa

Detalles Bibliográficos
Autores principales: Mrowczynski, Oliver D, Yang, Ae L, Liao, Jiangang, Rizk, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Neurosurgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389861/
https://www.ncbi.nlm.nih.gov/pubmed/34462698
http://dx.doi.org/10.7759/cureus.16675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389861/
https://www.ncbi.nlm.nih.gov/pubmed/34462698
http://dx.doi.org/10.7759/cureus.16675

Ejemplares similares